Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
Subnetwork: Myeloid malignancies
Disease group/s:
Scope and Purpose: 3. Treatment
Patients' involvement?: No
Rigour of development: A - Evidence and consensus based